A Review of Myeloablative vs Reduced Intensity/Non-Myeloablative Regimens in Allogeneic Hematopoietic Stem Cell Transplantations

Allogeneic hematopoietic stem cell transplantation (Allo-HSCT) is a curative treatment option for both malignant and some benign hematological diseases. During the last decade, many of the newer high-dose regimens in different intensity have been developed specifically for patients with hematologic...

Descripción completa

Detalles Bibliográficos
Autores principales: Atilla, Erden, Ataca Atilla, Pınar, Demirer, Taner
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Galenos Publishing 2017
Materias:
Invited Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5322516/
https://www.ncbi.nlm.nih.gov/pubmed/28251017
http://dx.doi.org/10.4274/balkanmedj.2017.0055

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5322516/
https://www.ncbi.nlm.nih.gov/pubmed/28251017
http://dx.doi.org/10.4274/balkanmedj.2017.0055

Ejemplares similares